Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin.
Nichola
N
Cooper
E Graham
EG
Davies
Adrian J
AJ
Thrasher
D000361:Agammaglobulinemia / Q000209:etiology* / Q000628:therapy; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D002648:Child; D006801:Humans; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors / Q000009:adverse effects*; D008297:Male; D000069283:Rituximab; D013921:Thrombocytopenia / Q000188:drug therapy* / Q000276:immunology
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D000069283:Rituximab